1-To improve field work interventions: improving and standardizing existing interventions reducing synthetic drugs related harm, facilitating their transferability and implementation.
2- To adapt responses to partygoers mobility: increasing harm reduction behaviors among tourist partygoers and reducing crisis situations in recreational settings.
3-To develop innovative responses adapted to youth cultures: developing individual harm reduction strategies through the use of interactive technology tools and emerging media.
4-To develop community empowerment: improving health settings and reducing harm related through community empowerment among European night clubs and events, implementing "Party+" labels within EU cities or regions and involving big summer festivals organizers in harm reduction responses.
5-To implement new projects and to enlarge the network: initiating and supporting emerging projects reducing synthetic drugs related harm in nightlife settings.
6-To improve the rapidity and quality of field responses in relation with new trends, new substances and adulterants.


The general objective of this project is to support efficient diagnosis, treatment, and research for the overlapping rare genetic diseases Wolfram, Alstrom and Bardet Biedl syndromes and other rarer diabetes syndromes in Europe. We will achieve this by implementing an EU registry for Rare Diabetes Syndromes (RDS), containing clinical, genetic diagnostic and outcome data. The purpose of the registry is: a) to establish the natural history of RDS (their characteristics, management and outcomes); b) to assess clinical effectiveness of management and quality of care; c) to provide an inventory of patients for recruitment to intervention studies; d) to establish genotype-phenotype correlations. We will achieve high usage of the registry by linking it to rapid genetic testing; and to up to date, accurate information, FAQS, and education material.
